Main Management ETF Advisors LLC Acquires 62,470 Shares of ARK Genomic Revolution ETF (BATS:ARKG)

Main Management ETF Advisors LLC lifted its stake in ARK Genomic Revolution ETF (BATS:ARKG) by 2.3% during the second quarter, HoldingsChannel reports. The firm owned 2,754,610 shares of the company’s stock after purchasing an additional 62,470 shares during the period. ARK Genomic Revolution ETF accounts for about 3.2% of Main Management ETF Advisors LLC’s holdings, making the stock its 12th largest position. Main Management ETF Advisors LLC’s holdings in ARK Genomic Revolution ETF were worth $64,678,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently added to or reduced their stakes in ARKG. BNP Paribas Financial Markets raised its stake in shares of ARK Genomic Revolution ETF by 101.5% during the first quarter. BNP Paribas Financial Markets now owns 2,330,573 shares of the company’s stock valued at $67,027,000 after acquiring an additional 1,173,872 shares in the last quarter. Goldman Sachs Group Inc. raised its position in ARK Genomic Revolution ETF by 271.4% during the 4th quarter. Goldman Sachs Group Inc. now owns 642,800 shares of the company’s stock valued at $21,090,000 after purchasing an additional 469,740 shares in the last quarter. Clearwater Capital Advisors LLC grew its position in shares of ARK Genomic Revolution ETF by 3.8% during the 1st quarter. Clearwater Capital Advisors LLC now owns 173,759 shares of the company’s stock worth $4,997,000 after buying an additional 6,385 shares in the last quarter. Cetera Investment Advisers grew its position in shares of ARK Genomic Revolution ETF by 290.7% during the 1st quarter. Cetera Investment Advisers now owns 140,897 shares of the company’s stock worth $4,052,000 after buying an additional 104,831 shares in the last quarter. Finally, Prudential PLC raised its holdings in shares of ARK Genomic Revolution ETF by 15.0% in the second quarter. Prudential PLC now owns 140,170 shares of the company’s stock valued at $3,326,000 after acquiring an additional 18,300 shares in the last quarter.

ARK Genomic Revolution ETF Stock Up 3.1 %

ARKG stock opened at $25.61 on Friday. The company has a fifty day moving average price of $25.73 and a 200-day moving average price of $25.68.

About ARK Genomic Revolution ETF

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.